Unexpected roles for the second brain: enteric nervous system as master regulator of bowel function

S Schneider, CM Wright… - Annual review of …, 2019 - annualreviews.org
At the most fundamental level, the bowel facilitates absorption of small molecules, regulates
fluid and electrolyte flux, and eliminates waste. To successfully coordinate this complex …

Weight gain and antidepressants

M Fava - Journal of Clinical Psychiatry, 2000 - psychiatrist.com
Weight gain during antidepressant treatment can be either a sign of improvement in patients
who have weight loss as a symptom of depression or a residual symptom in patients who …

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines …

DS Baldwin, IM Anderson, DJ Nutt… - Journal of …, 2014 - journals.sagepub.com
This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity

EJC Dunkley, GK Isbister, D Sibbritt, AH Dawson… - Qjm, 2003 - academic.oup.com
Background: There are difficulties with the diagnosis of serotonin toxicity, particularly with
the use of Sternbach's criteria. Aim: To improve the criteria for diagnosing clinically …

Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose

GK Isbister, SJ Bowe, A Dawson… - Journal of Toxicology …, 2004 - Taylor & Francis
Background: Selective serotonin reuptake inhibitors (SSRIs) have increasingly replaced
tricyclic antidepressants (TCAs) in the treatment of depression. They appear to be safer in …

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

EL Moses-Kolko, D Bogen, J Perel, A Bregar, K Uhl… - Jama, 2005 - jamanetwork.com
ContextA neonatal behavioral syndrome linked to in utero serotonin reuptake inhibitor (SRI)
exposure during the last trimester of pregnancy has been identified. The US Food and Drug …

Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan

EH Turner, JM Loftis, AD Blackwell - Pharmacology & therapeutics, 2006 - Elsevier
This paper reviews the preclinical and clinical evidence regarding the use of the dietary
supplement 5-hydroxytryptophan (5-HTP) for the treatment of depression. In the absence of …

The serotonin syndrome and its treatment

PK Gillman - Journal of Psychopharmacology, 1999 - journals.sagepub.com
Serotonin syndrome is caused by drug induced excess of intrasynaptic 5-hydroxytryptamine.
The clinical manifestations are mediated by the action of 5-hydroxytryptamine on various …

Current and potential drugs for treatment of obesity

GA Bray, FL Greenway - Endocrine reviews, 1999 - academic.oup.com
A. Peripherally acting agents B. Centrally acting agents IV. Drugs That Alter Metabolism A.
Preabsorptive agents B. Postabsorptive modifiers of nutrient metabolism V. Drugs That …

Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials

JL Pryor, SE Althof, C Steidle, RC Rosen… - The lancet, 2006 - thelancet.com
Background No drugs are approved for treatment of premature ejaculation. Our aim was to
determine the efficacy and tolerability of on-demand dapoxetine in patients with severe …